Gefitinib Stada

Gefitinib Stada is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Stada is primarily used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic markers. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its targeted approach to cancer therapy.

Common effects of Gefitinib Stada may include skin rash, diarrhea, and fatigue. Some users might experience nausea or loss of appetite. These effects can vary widely among individuals and are not exhaustive.

Gefitinib Stada should be handled with care, especially for those with pre-existing liver or kidney conditions. It is important to follow the advice of a healthcare professional regarding its use. Always store the medication in a safe place, away from children and pets.

Gefitinib Stada may interact with certain medications, including those that affect liver enzymes. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol and certain supplements might also influence its effectiveness.